Syphilis Non-Pregnant Patients VS. Pregnant Patients and Jarisch-Herxheimer Reaction

Syphilis, caused by the spirochete Treponema pallidum, is a sexually transmitted infection that progresses through distinct clinical stages if untreated. Management and follow-up differ between non-pregnant patients and pregnant women due to varying risks and outcomes.

---

1. Stages of Syphilis

A. Primary Syphilis

• Presentation:
  • A painless ulcer (chancre) at the site of inoculation (e.g., genitalia, anus).
  • Regional lymphadenopathy.
• Diagnosis:
  • Direct: Darkfield microscopy or direct fluorescent antibody tests from lesion exudates.
  • Serologic: Nontreponemal tests (e.g., RPR or VDRL) may be non-reactive early in the infection.

B. Secondary Syphilis

• Presentation: Systemic symptoms due to hematogenous dissemination, including:
  • Diffuse, maculopapular rash involving palms and soles.
  • Condyloma lata: Moist, wart-like lesions on mucous membranes.
  • Constitutional symptoms: Fever, malaise, and generalized lymphadenopathy.
• Diagnosis:
  • Serologic tests (RPR/VDRL) with confirmation using treponemal tests (e.g., FTA-ABS or TPPA).

C. Early Latent Syphilis

• Definition: Asymptomatic phase within the first year post-infection. Diagnosis is based on positive serology.

D. Late Latent Syphilis

• Definition: Asymptomatic infection lasting >1 year or of unknown duration, confirmed by positive serology.

E. Tertiary Syphilis

• Manifestations:
  • Cardiovascular: Aortitis, aortic aneurysm.
  • Neurosyphilis: Tabes dorsalis, general paresis, Argyll Robertson pupils.
  • Gummas: Granulomatous lesions in the skin, bones, or organs.
• Diagnosis:
  • Positive treponemal tests.
  • CSF analysis for neurosyphilis (elevated protein, pleocytosis, or reactive VDRL).

---

2. Syphilis in Pregnancy

Pregnant women with syphilis are at risk for severe complications, including stillbirth, preterm labor, and congenital syphilis.

Management Protocol for Pregnant Women

• Primary, Secondary, or Early Latent Syphilis:
  • Treatment: Benzathine penicillin G, 2.4 million units IM, single dose.
• Late Latent or Tertiary Syphilis (non-neurosyphilis):
  • Treatment: Benzathine penicillin G, 2.4 million units IM weekly for 3 weeks.
• Neurosyphilis:
  • Treatment: Aqueous crystalline penicillin G, 18–24 million units/day IV, divided into doses every 4 hours for 10–14 days.
• Penicillin Allergy: Perform desensitization, as penicillin is the only effective treatment during pregnancy.

---

3. Jarisch-Herxheimer Reaction

• Definition: A transient inflammatory response to antibiotic treatment due to the rapid lysis of spirochetes and release of inflammatory mediators.
• Clinical Features:
  • Occurs within 24 hours of initiating therapy.
  • Symptoms: Fever, chills, headache, myalgia, exacerbation of skin lesions.
• Management:
  • Administer antipyretics (e.g., acetaminophen) for symptomatic relief.
  • Do not discontinue antibiotics.
• Pregnancy Considerations:
  • May cause uterine contractions, preterm labor, or fetal distress.
  • Monitor the fetus closely during and after treatment.

---

4. Follow-Up and Monitoring

A. Non-Pregnant Patients

• Follow-Up Protocol:
  • Perform quantitative nontreponemal serology (e.g., RPR or VDRL) at 6, 12, and 24 months post-treatment.
  • Expect a fourfold decrease in titers by 6 months (e.g., 1:16 to 1:4).
  • A fourfold increase suggests reinfection or treatment failure, warranting re-evaluation.

B. Pregnant Women

• Follow-Up Protocol:
  • Conduct serologic testing monthly or every 3 months due to the increased risk of reinfection or treatment failure.
  • Expect a fourfold decrease in titers by 3 months post-treatment.
  • A fourfold increase in titers indicates reinfection or treatment failure, requiring retreatment.
• Fetal Monitoring:
  • Perform ultrasound to detect signs of congenital syphilis, including hepatosplenomegaly, hydrops fetalis, or placental thickening.

---

5. Management and Follow-Up Comparison

---

6. Key Points from CDC and WHO Guidelines

• Penicillin G remains the gold standard treatment for syphilis across all stages.
• Serologic titers (RPR/VDRL) are crucial for evaluating treatment efficacy and detecting reinfection.
• Pregnant women require closer monitoring due to risks to the fetus, with earlier expected serologic improvement.